Our Leadership Team

InSitu Biologics is an emerging biotech company focused on the development of AnestaGel™, a non-opiate painkiller. Meet the exceptional leaders that comprise our team:

Executive Team

Kevin Bassett MBA

Kevin Bassett, MBA

President & CEO

Kevin Bassett joined InSitu Biologics in September 2019 as President and CEO. Prior to joining Insitu, Mr. Bassett was General Manager of HLT Medical, a clinical-stage company developing a next-generation heart valve in the field of Transcatheter Aortic Valve Replacement (TAVR). Kevin has also served in a variety of senior executive roles in early-stage medical technology companies over the past twenty years.

Mr. Bassett is a certified public accountant (inactive license). He holds an M.B.A. from the Carlson School of Management at the University of Minnesota and a B.A. in Accounting and English from St. John’s University. Kevin also held a commission as an officer in the United States Army Reserves from 1991 – 2001.

Bill Taylor

Bill Taylor

Chief Science Officer

Bill is a Co-Founder of InSitu Biologics, beginning his work on the Matrix in 2007. Bill is a successful medical product development programs manager and scientist, and has been awarded over $900k in government research grants, and authored industry papers in chemical remediation and demilitarization utilizing biological systems.

Bill has his Bachelor of Science from the University of Minnesota with a double major in Chemical Engineering and Biology.

Board of Directors

James Knapp, CFP

Bio here: Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam laoreet risus in elit molestie imperdiet. Ut nunc arcu, efficitur sed pellentesque sed, pellentesque eget tortor. Mauris fermentum mauris volutpat orci fermentum laoreet. Sed id justo a sapien finibus consequat.

Sed maximus tellus eu interdum imperdiet. Curabitur rutrum, nulla porta ultricies vestibulum, ex lorem molestie tortor, sed aliquet tortor tellus sed nisl. Nulla facilisi. Suspendisse varius tristique metus. Donec ac pulvinar orci, nec vehicula ex. Donec ut augue elit.

Dr. Robert Wilson, MD

Robert F. Wilson, MD is an interventional cardiologist, entrepreneur, and Professor of Medicine. His work is focused on developing new methods and devices for diagnosing and treating heart disease. He founded Acist Medical Systems and developed the first semi-automated angiographic injection device. The CVi system is now a standard for coronary angiography worldwide and is used in over 2 million patients each year.

Dr. Wilson went on to found HLT, a company focused on development of a nitinol self-inverting transcatheter aortic valve, currently in a multicenter US clinical trial. In 2014, Dr. Wilson co-founded Egg Medical, Inc., which is commercializing a platform that reduces hospital x-ray lab staff scatter radiation exposure.

Dr. Wilson continues to part-time practice at the University of Minnesota.

Join Our Team

InSitu Biologics is currently seeking talented leaders to join our world-class Senior Management Team & Board of Directors here at our headquarters in Woodbury, MN. Interested candidates are encouraged to contact us for more information:

Or you may email info@insitubiologics.com